Assertio Holdings IncNASDAQ:ASRT
- LAST PRICE0.8780
- TODAY'S CHANGE (%)0.0300 (3.5377%)
- Bid / Lots0.8551/ 4
- Ask / Lots0.8787/ 4
- Open / Previous Close0.8400 / 0.8480
- Day Range
- 52 Week Range
- Volume112,722
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASRT |
|---|---|---|
| 09:32 ET | 14901 | 0.84 |
| 09:34 ET | 500 | 0.8316 |
| 09:36 ET | 3699 | 0.83 |
| 09:38 ET | 300 | 0.8324 |
| 09:45 ET | 1858 | 0.8401 |
| 09:48 ET | 100 | 0.830101 |
| 09:50 ET | 100 | 0.831 |
| 09:52 ET | 100 | 0.831 |
| 09:54 ET | 1773 | 0.835 |
| 09:56 ET | 2577 | 0.835 |
| 09:57 ET | 300 | 0.8418 |
| 10:03 ET | 2700 | 0.8499 |
| 10:06 ET | 195 | 0.84495 |
| 10:08 ET | 200 | 0.8419 |
| 10:10 ET | 282 | 0.84745 |
| 10:12 ET | 2518 | 0.8498 |
| 10:15 ET | 175 | 0.84745 |
| 10:17 ET | 800 | 0.845 |
| 10:19 ET | 2271 | 0.84745 |
| 10:21 ET | 200 | 0.84745 |
| 10:26 ET | 262 | 0.84745 |
| 10:30 ET | 15124 | 0.8437 |
| 10:32 ET | 3481 | 0.838 |
| 10:33 ET | 151 | 0.8437 |
| 10:35 ET | 266 | 0.8499 |
| 10:37 ET | 200 | 0.8499 |
| 10:39 ET | 464 | 0.84375 |
| 10:42 ET | 987 | 0.8437 |
| 10:44 ET | 1300 | 0.8499 |
| 10:46 ET | 1259 | 0.838 |
| 10:48 ET | 1160 | 0.86 |
| 10:50 ET | 6857 | 0.85055 |
| 10:51 ET | 400 | 0.855 |
| 10:53 ET | 200 | 0.855 |
| 10:55 ET | 458 | 0.855 |
| 10:57 ET | 800 | 0.855 |
| 11:00 ET | 476 | 0.84875 |
| 11:02 ET | 600 | 0.855 |
| 11:04 ET | 300 | 0.855 |
| 11:06 ET | 12154 | 0.861 |
| 11:08 ET | 4000 | 0.861 |
| 11:09 ET | 3649 | 0.872 |
| 11:11 ET | 400 | 0.878 |
| 11:13 ET | 632 | 0.878 |
Apr 25, 2024
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024, from 8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 3, 2024
Sig Kirk Joins Assertio Board of Directors, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow JonesPress Release: Sig Kirk Joins Assertio Board of Directors, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 1, 2024
Assertio to Present at LD Micro Invitational Conference in New York City, from 9:00AM ET on Monday Apr 01, 2024 by Dow Jones
9:00AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Assertio Holdings Inc | 80.7M | -0.2x | --- |
Natural Alternatives International Inc | 37.9M | -8.8x | -18.19% |
SCYNEXIS Inc | 68.7M | 1.3x | --- |
American Oriental Bioengineering Inc | 30.0 | 0.0x | --- |
Takeda Pharmaceutical Co Ltd | 41.6B | 36.5x | -3.20% |
Xeris Biopharma Holdings Inc | 259.4M | -3.9x | --- |
Company Information
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Contact Information
- Headquarters
- 100 S. Saunders Road, Suite 300LAKE FOREST, IL, United States 60045
- Phone
- 224-419-7106
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Peter Staple
- Interim Chief Executive Officer, Director
- Heather Mason
- Chief Financial Officer, Senior Vice President, Chief Accounting Officer
- Ajay Patel
- Senior Vice President, General Counsel, Executive Officer
- Sam Schlessinger
- Senior Vice President, Chief Commercial Officer
- Paul Schwichtenberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $80.7M |
|---|---|
Revenue (TTM) | $152.1M |
Shares Outstanding | 95.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-3.97 |
Book Value | $1.46 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -166.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
